Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 122 shares (to pay taxes)
  2. 4 Planned sale Head of Development sold 81 shares at $282.87 ($22,912)
  3. 4 Grant or award Director acquired 960 shares (grant or award)
  4. 4 Grant or award Director acquired 960 shares (grant or award)
  5. 4 Grant or award Director acquired 960 shares (grant or award)
  6. 4 Grant or award Director acquired 960 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 960 shares (grant or award)
  9. 4 Grant or award Director acquired 960 shares (grant or award)
  10. 4 Grant or award Director acquired 1,580 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale EVP, Human Resources sold 2,681 shares at $300.00 ($804,300)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Planned sale Head of Development sold 91 shares at $277.11 ($25,217)
  15. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 116 shares (to pay taxes)
  16. 4 Open-market sale Head of Development sold 568 shares at $270.06 ($153,394)
  17. 4 Shares withheld for taxes Head of Development gave up 687 shares (to pay taxes)
  18. 4 Shares withheld for taxes Head of Development gave up 151 shares (to pay taxes)
  19. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 233 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,310 shares (to pay taxes)

Page 8 of 86 · 1,714 filings